Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Replication protein A 30 kDa subunit (RPA4) is a component of the replication protein A (RPA) complex, a heterotrimeric single-stranded DNA-binding factor essential for eukaryotic DNA metabolism[1][2][3][4][5]. RPA4 substitutes for the canonical RPA2 subunit in certain contexts and participates in DNA replication, repair (notably nucleotide excision repair), homologous recombination, and cell cycle checkpoint activation[1][4][5]. It binds single-stranded DNA to prevent secondary structure formation and protect DNA during processing, and is involved in assembling or recruiting repair and replication proteins to sites of DNA damage or replication stress[1][4][5]. RPA4 has distinct expression patterns and appears important in specific tissues (e.g., colon, placenta)[4], localizes to DNA repair foci, and may contribute to cellular DNA damage responses and inhibition of viral replication[5]. Its role in cancer and response to genotoxic stress is an area of ongoing research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Replication protein A 30 kDa subunit (RPA4).